Search Options Stock News and Analysis from Schaeffer's

Akero Therapeutics Stock Surges on Novo Nordisk Buyout

https://www.schaeffersresearch.com/content/news/2025/10/09/akero-therapeutics-stock-surges-on-novo-nordisk-buyout

10/9/2025 10:11 AM

Novo Nordisk A/S (NYSE:NVO) is down 1% to trade at $59 this morning, after news surfaced that the pharmaceutical concern has entered an agreement to purchase U.S.-based peer Akero Therapeutics Inc (...

Ozempic Parent Announces 9,000 Job Cuts in Restructuring Plan

https://www.schaeffersresearch.com/content/news/2025/09/10/ozempic-parent-announces-9-000-job-cuts-in-restructuring-plan

9/10/2025 10:54 AM

Pharmaceutical name Novo Nordisk A/S (NYSE:NVO), the maker of weight-loss drugs Wegovy and Ozempic, is in the spotlight today after announcing roughly 9,000 job cuts and slashing its full-year guidan...

FDA Win Boosts Struggling Pharmaceutical Stock

https://www.schaeffersresearch.com/content/news/2025/08/18/fda-win-boosts-struggling-pharmaceutical-stock

8/18/2025 9:52 AM

Pharmaceutical powerhouse Novo Nordisk (NYSE:NVO) is charging 3.1% higher to trade at $54.10, after its weight-loss drug Wegovy landed Food and Drug Administration (FDA) approval to be used in the tr...

Tariffs, Earnings, Economic Data, and More This Past Week

https://www.schaeffersresearch.com/content/news/2025/08/01/tariffs-earnings-economic-data-and-more-this-past-week

8/1/2025 2:21 PM

Though the Dow Jones Industrial Average (DJI), S&P 500 Index (SPX), and Nasdaq Composite Index (IXIC) all posted strong monthly gains on Thursday, they're all headed for firm weekly losses. The Dow...

Novo Nordisk Stock Eyes Worst Day Ever After Forecast Cut

https://www.schaeffersresearch.com/content/news/2025/07/29/novo-nordisk-stock-eyes-worst-day-ever-on-outlook-cut

7/29/2025 10:01 AM

Pharma giant Novo Nordisk A/S (NYSE:NVO) is plunging 21% to trade at a nearly three-year low of $54.27, after the company's surprise cut to its full-year guidance due to a lower sales outlook for seve...

PEOPLE ALSO SEARCH FOR